ENGY yields 20000000.00% · JNJ yields 2.13%● Live data
📍 ENGY pulled ahead of the other in Year 1
Combined, ENGY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ENGY + JNJ for your $10,000?
Central Energy Partners LP, through its subsidiary, Regional Enterprises, Inc., provides liquid bulk storage, trans-loading, and transportation services for hazardous chemicals and petroleum products in the United States. It transports hazardous liquid products, such as aluminum sulfate solution, hydrochloric and sulfuric acid, sodium hydroxide, aqua ammonia, sodium bisulfate, and fuel blends; and non-hazardous materials, including crude tall oil, No. 2 oil, No. 6 oil, asphalt additives, micro-c, and vacuum gas oil in the states of Virginia, North Carolina, South Carolina, Georgia, Tennessee, Maryland, Pennsylvania, and Delaware. The company also offers tank storage and terminal services. As December 31, 2014, it had a fleet of 15 leased tractors, 5 owned tractors, and 36 tanker units for transportation services. Central Energy GP LLC serves as the general partner of Central Energy Partners LP. The company was formerly known as Rio Vista Energy Partners L.P. and changed its name to Central Energy Partners LP in December 2010. Central Energy Partners LP was founded in 2003 and is based in Dallas, Texas.
Full ENGY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.